期刊文献+

食管癌中TOP2A的表达及临床意义 被引量:2

Expression of topoisomerase Ⅱ alpha in human esophageal carcinoma and its clinical significance
暂未订购
导出
摘要 目的探讨TOP2A在食管癌和癌旁组织中的表达及其与食管癌发生发展、侵袭转移的关系。方法采用免疫组织化学(SP法)染色法及逆转录-聚合酶链反应(RT-PCR法)对62例食管癌(食管癌组)及38例相应的癌旁组织中(对照组)的TOP2A蛋白及转录水平的表达进行检测,并行统计学分析。结果 TOP2A蛋白在食管癌组织中的表达高于癌旁组织(对照组),且与癌组织的浸润程度、淋巴结转移、癌组织分化程度及临床预后密切相关(P<0.05)。TOP2A基因的mRNA及蛋白表达与肿瘤分级、淋巴结情况相关。结论 TOP2A的表达与食管癌发生发展、侵袭转移关系较密切,可作为判断食管癌患者诊断、治疗及生存预后的病理学指标之一。 Objective To discuss the correlation between the expression of topoisomerase 2 alpha (TOP2A) and the biological Behaviors (cancer occurrence, development, invasion and metastasis) of human esophageal cell carcinoma (ESCC). Methods Immunohistochemistry and reverse transcription polymerase chain reaction (RT-PCR) was used to detect the expression of TOP2A in 62 cases of ESCC specimens and 38 cases of non-cancerous tissue. The results were used for statistical analysis. Results The protein and mRNA expressions of TOP2A were significantly correlated to the invasion dept, lymphatic transmission and prognosis (P 〈0.05) and the differentiation of the tumor was also significant. The expression of TOP2A in esophageal carcinoma was higher than the cases of non-cancerous tissue which lie more than 5 centimeter on the ESCC tissue (P 〈0.05). Conclusion TOP2A plays an important role in the invasion and metastasis of the esophageal carcinomas, and may serve as a valuable indicator for the diagnosis, treatment and the prognostic evaluation of the malignant.
出处 《新疆医科大学学报》 CAS 2013年第5期623-626,共4页 Journal of Xinjiang Medical University
关键词 食管癌 TOP2A 免疫组织化学 逆转录聚合酶链反应 esophageal topoisomerase 2 alpha immunohistochemistry reverse transcription polymerase chain reaction
  • 相关文献

参考文献12

  • 1Orlando L, Del Curto B, Gandini S, et al. Topoisomerase Ⅱ alha gene status and prediction of pathological complete remis-sion after anthracycline-based neoadjuvant chemotherapy in en- docrine nowresponsive Her2/neu-positive breast cancer [J]. Breast, 2008,17 : 506-511.
  • 2Tanner M, Isola J, Wiklund T, et al. Topoisomemse Ⅱ alpha gene amplification predicts favorable treatment response to tai- lored and dose-escalated anthracycline-based adjuvant chemo- therapy in HER-2/neu-amplified breast cancer: Seandinavian Breast Group Trial 9401[J]. Clin Oncol, 2006,24 :2428-2436.
  • 3Akagi T, Ito T, Kato M, et al. Chromosomal abnormalities and novel disease-related regions in progression from Barret's esophagus to esophageal adenocarcin [J]. Int Cancer, 2009, 125 : 2349-2359.
  • 4Park K, Han S, Gwak GH, et al. Topoisomerase Ⅱ-alpha gene deletion is not frequent as its amplification in breast canc- er[J]. Breast Cancer Res Treat, 2006,98 : 337-342.
  • 5Parker LP, Taylor DD, Kesterson S, et al. Gene expression profiling in response to estradiol and genistein in ovarian canc- er cells[J]. Cancer Genomies Proteomis, 2009,6 : 189-194.
  • 6Lo Muzio LL, Farina A, Robini C, et al. Survivin as prognos tic factor in squamous cell carcinoma of the oral cavity[J]. Cancer Lett,2005,225(1) :27-33.
  • 7依马木买买提江.阿布拉,阿迪力.萨来,张国庆,孙伟,王洪江,斯坎达尔.阿布力孜,庞作良.胸段食管鳞癌淋巴结转移影响因素的探讨[J].新疆医科大学学报,2010,33(4):415-417. 被引量:3
  • 8Varis A, Wolf M, Monni O, et al. Targets of gene amplifiea tion and over expression at 17q in gastric cancer[J]. Cancer Res, 2002,62 : 2625-2629.
  • 9Wikman H, Kettunen E, Seppanen JK, et al. Identification of differentially expressed genes in pulmonary adenocarcinnoma by using cDNA array[J]. Oncogene, 2002,21: 5804-5813.
  • 10Liang Z, Zeng X, Gao J, et al Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinnoma from Chinese patients[J]. BMC Cancer , 2008,8:363- 367.

二级参考文献12

  • 1黄金球,安丰山.胸段食管癌淋巴结转移规律的临床研究[J].现代肿瘤医学,2004,12(3):227-228. 被引量:4
  • 2谢映涛,王树钦,黄金球,安丰山,陈少湖.影响胸段食管鳞癌切除术预后的因素[J].中华胃肠外科杂志,2004,7(6):453-455. 被引量:20
  • 3张亚伟,相加庆,李方明,胡鸿,缪珑升,马龙飞,李鹤成,张杰.胸段食管癌手术治疗后的死因与复发类型[J].中国癌症杂志,2006,16(10):831-834. 被引量:22
  • 4Nishimaki T. An Appropriate esophagectomy for esophageal cancer: A lack of evidence and a growing disparitybetween western and eastern standards [J]. Ann Thorac Cardiovasc Surg,2006,12(4) :231-233.
  • 5Aiko S, Yoshizumi Y, Ishizuka R. Reduction rate of lymph node metastasis as a significant prognostic factor in esophageal cancer patients treated with neoadjuvant ehemoradiation therapy[J]. Dis Esophagus,2007, 20(2) :94-101.
  • 6Mastusbara T, Ueda M, Abe T, et al. Unique distribution pentanes with superficial carcinoma of the thoracic esophagus [J]. Br J Surg, 1999, 86:669-673.
  • 7Hagen JA, DeMeester SR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies[J]. Ann Surg, 2001, 234(4):520-530.
  • 8Tachibana M, Yoshimura H, Kinugara S, et al. Clinicopathologic factors correlated with number of metastatic lymph nodes in esophageal caneer[J]. Diliver Dis, 2001, 33(7):534-538.
  • 9Nigro JJ, Hagen JA, DeMeester TR, et al. Prevalanec and location of nodal metastasis in distal esophageal adenoearecinoma confined to the wall :implication for theraphy[J]. J Thorac Cardiovase Surg, 1999, 117 : 16-25.
  • 10Xiao ZF, Yang ZY, Miao YJ, et al. Influenee of number of metastatie lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases[J]. Int J Radiat Oneol Biol Phys, 2005, 62 (1) :82-90.

共引文献2

同被引文献8

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部